Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The use of ozone therapy in Buruli ulcer had an excellent outcome.

Bertolotti A, Izzo A, Grigolato PG, Iabichella ML.

BMJ Case Rep. 2013 Jan 31;2013. pii: bcr2012008249. doi: 10.1136/bcr-2012-008249.

2.

Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya.

Walsh DS, Eyase F, Onyango D, Odindo A, Otieno W, Waitumbi JN, Bulimo WD, Schnabel DC, Meyers WM, Portaels F.

Am J Trop Med Hyg. 2009 Dec;81(6):1110-3. doi: 10.4269/ajtmh.2009.09-0313.

PMID:
19996445
3.

Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).

Kibadi K, Boelaert M, Fraga AG, Kayinua M, Longatto-Filho A, Minuku JB, Mputu-Yamba JB, Muyembe-Tamfum JJ, Pedrosa J, Roux JJ, Meyers WM, Portaels F.

PLoS Negl Trop Dis. 2010 Jul 6;4(7):e736. doi: 10.1371/journal.pntd.0000736.

4.

Spontaneous clearance of Mycobacterium ulcerans in a case of Buruli ulcer.

Gordon CL, Buntine JA, Hayman JA, Lavender CJ, Fyfe JA, Hosking P, Johnson PD.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1290. doi: 10.1371/journal.pntd.0001290. Epub 2011 Oct 25. No abstract available.

5.

Buruli ulcer in an 18-day-old baby.

Kiiza AM, Wood PB.

Trop Doct. 2012 Jan;42(1):48. doi: 10.1258/td.2011.110230. Epub 2011 Nov 11.

PMID:
22080481
6.

Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection.

Pommelet V, Vincent QB, Ardant MF, Adeye A, Tanase A, Tondeur L, Rega A, Landier J, Marion E, Alcaïs A, Marsollier L, Fontanet A, Chauty A.

Clin Infect Dis. 2014 Nov 1;59(9):1256-64. doi: 10.1093/cid/ciu584. Epub 2014 Jul 21.

PMID:
25048846
7.

Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era.

Webb BJ, Hauck FR, Houp E, Portaels F.

East Afr J Public Health. 2009 Aug;6(2):144-7. Review.

PMID:
20000019
8.

Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?

Ruf MT, Chauty A, Adeye A, Ardant MF, Koussemou H, Johnson RC, Pluschke G.

PLoS Negl Trop Dis. 2011 Aug;5(8):e1252. doi: 10.1371/journal.pntd.0001252. Epub 2011 Aug 2.

9.

New foci of Buruli ulcer, Angola and Democratic Republic of Congo.

Kibadi K, Panda M, Tamfum JJ, Fraga AG, Longatto Filho A, Anyo G, Pedrosa J, Nakazawa Y, Suykerbuyk P, Meyers WM, Portaels F.

Emerg Infect Dis. 2008 Nov;14(11):1790-2. doi: 10.3201/eid1411.071649.

10.

Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.

Klis S, Kingma RA, Tuah W, van der Werf TS, Stienstra Y.

Trop Med Int Health. 2016 Sep;21(9):1191-6. doi: 10.1111/tmi.12745. Epub 2016 Jul 26.

PMID:
27456068
11.

Clinical considerations on Buruli ulcer employing two molecular tests for the detection of Mycobacterium ulcerans in 100 skin biopsies.

Leigheb G, Zavattaro E, Molicotti P, Cannas S, Zanetti S, Clemente C, Johnson RC, Sopoh GE, Dossou AD, Colombo E.

Int J Dermatol. 2014 Feb;53(2):213-20. doi: 10.1111/ijd.12249. Epub 2013 Dec 10.

PMID:
24320698
12.

Spontaneous clearance of a secondary Buruli ulcer lesion emerging ten months after completion of chemotherapy--a case report from Togo.

Beissner M, Piten E, Maman I, Symank D, Jansson M, Nitschke J, Amekuse K, Kobara B, Wiedemann F, Hoffmann H, Diefenhardt A, Badziklou K, Banla Kere A, Löscher T, Bretzel G.

PLoS Negl Trop Dis. 2012;6(7):e1747. doi: 10.1371/journal.pntd.0001747. Epub 2012 Jul 31. No abstract available.

13.

[Mycobacterium ulcerans disease (Buruli ulcer) in Gabon: 2005-2011].

Bayonne Manou LS, Portaels F, Eddyani M, Book AU, Vandelannoote K, de Jong BC.

Med Sante Trop. 2013 Oct-Dec;23(4):450-7. doi: 10.1684/mst.2013.0259. French.

14.

Laboratory diagnosis of Buruli ulcer disease.

Beissner M, Herbinger KH, Bretzel G.

Future Microbiol. 2010 Mar;5(3):363-70. doi: 10.2217/fmb.10.3. Review.

PMID:
20210548
15.

Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.

Iddrisah FN, Yeboah-Manu D, Nortey PA, Nyarko KM, Anim J, Antara SN, Kenu E, Wurapa F, Afari EA.

Pan Afr Med J. 2016 Oct 1;25(Suppl 1):13. doi: 10.11604/pamj.supp.2016.25.1.6203. eCollection 2016.

16.

[Infection with mycobacterium ulcerans (Buruli ulcer): still a neglected disease in 2009?].

Françoise P.

Med Trop (Mars). 2009 Oct;69(5):429-30. French. No abstract available.

PMID:
20025166
17.

Nineteen cases of Buruli ulcer diagnosed in Japan from 1980 to 2010.

Nakanaga K, Hoshino Y, Yotsu RR, Makino M, Ishii N.

J Clin Microbiol. 2011 Nov;49(11):3829-36. doi: 10.1128/JCM.00783-11. Epub 2011 Aug 31.

18.

Buruli ulcer caused by "Mycobacterium ulcerans subsp. shinshuense".

Watanabe T, Ohkusu K, Nakanaga K, Ishii N, Nakashima K, Shindo M, Yoshida Y, Yamamoto O.

Eur J Dermatol. 2010 Nov-Dec;20(6):809-10. doi: 10.1684/ejd.2010.1067. Epub 2010 Sep 7. No abstract available.

PMID:
20822972
19.

Health services for Buruli ulcer control: lessons from a field study in Ghana.

Ackumey MM, Kwakye-Maclean C, Ampadu EO, de Savigny D, Weiss MG.

PLoS Negl Trop Dis. 2011 Jun;5(6):e1187. doi: 10.1371/journal.pntd.0001187. Epub 2011 Jun 21.

20.

Factors enhancing the control of Buruli ulcer in the Bomfa communities, Ghana.

Agbenorku P, Agbenorku M, Amankwa A, Tuuli L, Saunderson P.

Trans R Soc Trop Med Hyg. 2011 Aug;105(8):459-65. doi: 10.1016/j.trstmh.2011.05.003. Epub 2011 Jun 8.

PMID:
21652052

Supplemental Content

Support Center